Considering the fact that thromboembolic complications are commonly observed in patients with severe COVID-19, as well as our findings showing that the expression of APC signaling-related genes is downregulated in patients with COVID-19, we propose that APC dysfunction in severe COVID-19 could be involved in the development of COVID-19-associated coagulopathy. This evidence concerns the gene APC and blood coagulation disease.